LDN-072

N/A

Report date: 2024/01/09 12:10:31
NMEFirst In Class

Base Information

Drug NameLDN-072
Drug Alias NameLDN-072
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHungary
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLadon Therapeutics Kft
China Registration ClassN/A

Develop Information

Active CompaniesLadon Therapeutics Kft
Inactive CompaniesN/A
Active IndicationsFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A